108 related articles for article (PubMed ID: 7528485)
1. [Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the dose on the efficacy of the long term treatment].
Leclere J
Ann Endocrinol (Paris); 1994; 55(1):11-4. PubMed ID: 7528485
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the effect of the duration of medical treatment on its long term efficacy].
Allannic H
Ann Endocrinol (Paris); 1994; 55(1):7-10. PubMed ID: 7528488
[TBL] [Abstract][Full Text] [Related]
3. Antithyroid drugs--a rational treatment for Graves' disease?
Leclère J
Horm Res; 1987; 26(1-4):125-30. PubMed ID: 2439425
[TBL] [Abstract][Full Text] [Related]
4. [Basedow disease hyperthyroidism--is there a therapeutic standard? Conservative therapy].
Schumm-Draeger PM
Zentralbl Chir; 1997; 122(4):224-6. PubMed ID: 9221630
[TBL] [Abstract][Full Text] [Related]
5. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
[TBL] [Abstract][Full Text] [Related]
6. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
7. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
8. [Long-term follow up after antithyroid drug treatment in Graves' disease].
Wille T; Müller B; Noth D; Bürgi U; Diem P
Praxis (Bern 1994); 2006 Jul; 95(29-30):1121-7. PubMed ID: 16916174
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Choo YK; Yoo WS; Kim DW; Chung HK
Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
[TBL] [Abstract][Full Text] [Related]
10. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
11. [Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy].
Allannic H; Lorcy Y; Leguerrier AM; Delambre C; Stetieh H; Madec AM; Orgiazzi J
Presse Med; 1991 Apr; 20(14):645-6, 649-51. PubMed ID: 1710802
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
14. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study.
Léger J; Gelwane G; Kaguelidou F; Benmerad M; Alberti C;
J Clin Endocrinol Metab; 2012 Jan; 97(1):110-9. PubMed ID: 22031519
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in children and adolescents: response to long-term treatment.
Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of antithyroid drug therapy of Graves' disease.
Feldt-Rasmussen U; Glinoer D; Orgiazzi J
Annu Rev Med; 1993; 44():323-34. PubMed ID: 7682804
[TBL] [Abstract][Full Text] [Related]
17. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
18. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
19. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
20. Strategy for antithyroid drug therapy in Graves' disease.
Allannic H
Horm Res; 1987; 26(1-4):146-53. PubMed ID: 2439428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
